ACTIVITY OF OMEPRAZOLE ON HELICOBACTER-PYLORI AND RELATION TO TOXICITY OF STRAINS

被引:13
作者
FIGURA, N
ARMELLINI, D
BUGNOLI, M
BAYELI, PF
GENNARI, C
CRABTREE, JE
机构
[1] IRIS,SIENA,ITALY
[2] ST JAMESS UNIV HOSP,DEPT MED,LEEDS,ENGLAND
关键词
D O I
10.1136/jcp.47.5.440
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Aims-To see whether the activity of omeprazole on Helicobacter pylori is associated with toxicity of strains; to determine whether omeprazole inhibited vacuolisation of cells in culture induced by H pylori cytotoxin and by ureas, and if omeprazole prevented H pylori motility. Methods-Minimal inhibitory concentrations (MICs) of omeprazole were determined for seven cytotoxic and five non-cytotoxic H pylori strains. Omeprazole at different concentrations was incubated with cytotoxic and non-cytotoxic extracts of H pylori, or with purified H pylori urease, and added to cells in culture. Inhibition of motility by omeprazole was tested in semi-solid medium. Results-MIC(90) of omeprazole was 40 mu g/ml. MICs for cytotoxic and non-cytotoxic organisms were similar. Omeprazole did not prevent vacuolisation induced by the cytotoxic extract, but at high concentrations it inhibited the formation of vacuoles induced by urease. Motility was not inhibited by the drug. Conclusions-H pylori cytotoxin is not the target of the antimicrobial activity of omeprazole. Should the drug reach clinically effective concentrations in vivo, it could potentially prevent the mucosal damage caused by the vacuolising activity of urease.
引用
收藏
页码:440 / 442
页数:3
相关论文
共 9 条
[1]  
BELL GD, 1991, EUR J GASTROEN HEPAT, V3, P923
[2]   INHIBITION OF HELICOBACTER-PYLORI UREASE BY OMEPRAZOLE [J].
BUGNOLI, M ;
BAYELI, PF ;
RAPPUOLI, R ;
PENNATINI, C ;
FIGURA, N ;
CRABTREE, JE .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1993, 5 (09) :683-685
[3]   EFFECT OF UREASE ON HELA-CELL VACUOLATION INDUCED BY HELICOBACTER-PYLORI CYTOTOXIN [J].
COVER, TL ;
PURYEAR, W ;
PEREZPEREZ, GI ;
BLASER, MJ .
INFECTION AND IMMUNITY, 1991, 59 (04) :1264-1270
[4]  
COVER TL, 1992, J BIOL CHEM, V267, P10570
[5]  
DAW MA, 1991, ALIMENT PHARM THERAP, V5, P435
[6]   PURIFICATION AND N-TERMINAL ANALYSIS OF UREASE FROM HELICOBACTER-PYLORI [J].
HU, LT ;
MOBLEY, HLT .
INFECTION AND IMMUNITY, 1990, 58 (04) :992-998
[7]   LANSOPRAZOLE, A NOVEL BENZIMIDAZOLE PROTON PUMP INHIBITOR, AND ITS RELATED-COMPOUNDS HAVE SELECTIVE ACTIVITY AGAINST HELICOBACTER-PYLORI [J].
IWAHI, T ;
SATOH, H ;
NAKAO, M ;
IWASAKI, T ;
YAMAZAKI, T ;
KUBO, K ;
TAMURA, T ;
IMADA, A .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (03) :490-496
[8]   BIOTYPES AND DNA FINGERPRINTS OF CYTOTOXIGENIC HELICOBACTER-PYLORI FROM PATIENTS WITH GASTRITIS AND PEPTIC-ULCERATION IN ITALY [J].
OWEN, RJ ;
FIGURA, N ;
MORENO, M .
EUROPEAN JOURNAL OF EPIDEMIOLOGY, 1992, 8 (01) :15-21
[9]   BAFILOMYCIN-A1 INHIBITS HELICOBACTER-PYLORI-INDUCED VACUOLIZATION OF HELA-CELLS [J].
PAPINI, E ;
BUGNOLI, M ;
DEBERNARD, M ;
FIGURA, N ;
RAPPUOLI, R ;
MONTECUCCO, C .
MOLECULAR MICROBIOLOGY, 1993, 7 (02) :323-327